Transcription inhibition using oligonucleotide-modified gold nanoparticles.
暂无分享,去创建一个
Chiamaka Agbasi-Porter | S. Franzen | D. Feldheim | Jessica P. Ryman-Rasmussen | Stefan Franzen | Jessica Ryman-Rasmussen | Daniel Feldheim | Chiamaka Agbasi-Porter
[1] Chad A Mirkin,et al. A thermodynamic investigation into the binding properties of DNA functionalized gold nanoparticle probes and molecular fluorophore probes. , 2005, Journal of the American Chemical Society.
[2] J. Messing,et al. A new opaque variant of maize by a single dominant RNA-interference-inducing transgene. , 2003, Genetics.
[3] R. Levine,et al. New Efficient Catheter-Based System for Myocardial Gene Delivery , 2002, Circulation.
[4] Y. Cho‐Chung. Antisense and therapeutic oligonucleotides: toward a gene-targeting cancer clinic , 2000 .
[5] M. Gleave,et al. A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells , 2005, Molecular Cancer Therapeutics.
[6] M. Mann,et al. Therapeutic applications of transcription factor decoy oligonucleotides. , 2000, The Journal of clinical investigation.
[7] S. Franzen,et al. Multifunctional gold nanoparticle-peptide complexes for nuclear targeting. , 2003, Journal of the American Chemical Society.
[8] D. Scadden,et al. Ex vivo targeting of p21Cip1/Waf1 permits relative expansion of human hematopoietic stem cells. , 2003, Blood.
[9] E. Pearce,et al. Transgene expression in Schistosoma mansoni: introduction of RNA into schistosomula by electroporation. , 2004, Molecular and biochemical parasitology.
[10] Glenn P. Goodrich,et al. Hybridization and enzymatic extension of au nanoparticle-bound oligonucleotides. , 2002, Journal of the American Chemical Society.
[11] C. Mirkin,et al. A two-color-change, nanoparticle-based method for DNA detection. , 2005, Talanta.
[12] Chad A. Mirkin,et al. One-Pot Colorimetric Differentiation of Polynucleotides with Single Base Imperfections Using Gold Nanoparticle Probes , 1998 .
[13] R. Morishita,et al. Antisense oligonucleotides as a powerful molecular strategy for gene therapy in cardiovascular diseases. , 2004, Current pharmaceutical design.
[14] S. Woo,et al. Downregulation of human type III collagen gene expression by antisense oligodeoxynucleotide. , 2005, Tissue engineering.
[15] J. Grandis,et al. In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy , 2005, Oncogene.
[16] Federica Gemignani,et al. Systemically delivered antisense oligomers upregulate gene expression in mouse tissues , 2002, Nature Biotechnology.
[17] A. Sinskey,et al. Manipulating gene expression for the metabolic engineering of plants. , 2002, Metabolic engineering.
[18] M. K. Brennaman,et al. Critical flocculation concentrations, binding isotherms, and ligand exchange properties of peptide-modified gold nanoparticles studied by UV-visible, fluorescence, and time-correlated single photon counting spectroscopies. , 2003, Analytical chemistry.
[19] Yanli Liu,et al. Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains. , 2004, Bioconjugate chemistry.
[20] Young-Chae Chang,et al. E2F decoy oligodeoxynucleotides effectively inhibit growth of human tumor cells. , 2003, Biochemical and biophysical research communications.
[21] Y. Inagaki,et al. Interferon-γ Interferes with Transforming Growth Factor-β Signaling through Direct Interaction of YB-1 with Smad3* , 2003, Journal of Biological Chemistry.
[22] A. Steel,et al. Electrochemical quantitation of DNA immobilized on gold. , 1998, Analytical chemistry.